Daily Equity Reports 24 Jan 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 24 THJANUARY 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 3644.64 INDIAN EQUITY BENCHMARK - Sensex down over 330 points; Nifty below 10,850, At the close of market hours, the Sensex was down 336.17 points or 0.92% at 36108.47, and the Nifty down 91.30 points or 0.84% at 10831.50. GLOBAL FACE NIFTY 10922.75 ASIAN MARKET CLOSE PREVIOUS NIKKEI ! Asian Market - Asian markets finished mixed as of the most recent closing prices. The Shanghai Composite gained 0.05% and the Hang Seng rose 0.01%. The Nikkei 225 lost 0.14%. 2127.78 2117.77 SECTORIAL INDICES ! CLOSE CHANGE (%) U.S. Market – North and South American markets finished broadly lower on Tuesday with shares in U.S. leading the region. The S&P 500 is down 1.42% while Brazil's Bovespa is CNX 100 off 0.94% and Mexico's IPC is lower by 0.59%. S&P CNX 500 9068.85 4795.85 ! CNX 200 5700.45 European markets European markets are mixed. The CAC 40 is higher by 0.18%, while the FTSE 100 is leading the DAX lower. They are down 0.25% and 0.09% respectively. TOP GAINERS CLOSE CHANGE (%) 2.73 SUNPHARMA 430.40 2.63 YESBANK 197.25 1.43 TATASTEEL 463.10 1.30 WIPRO 351.00 TOP LOSERS CLOSE CHANGE (%) ITC 276.00 GRASIM 780.50 IBULHSGFIN 777.15 TITAN 960.00 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE TREND BULLISH STRATEGY SCRIPT CLOSE (%) 7.30 GRANUELS 93.30 PIVOT POINTS 5.94 S3 10597 S2 10729 R1 10913 R2 10995 R3 11128 NAUKRI 1729.05 10780 10862 3.09 JUBILANT 757.20 S1-10780 S2-10729 R1-10913 R2-10995 2.92 HATHWAY 31.75 CLOSE (%) ICICIPRULI 305.40 -4.30 ITC 277.30 TVSMOTOR -4.09 531.55 -3.06 STAR 531.50 NET BUY (CR.) NET INSTITUTION SELL (CR) STRATEGY SELL ON RISE BEARISH 5308.21 PIVOT POINTS P 27394 S3 S1 27178 R1 R2 R3 28067 DII 3342.42 26721 27058 27514 27790 RESISTANCE NSE TOTALS ADVANCE BANK NIFTY S NIFTY BANK NIFTY 9 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report ! ! Maruti Suzuki launches 3rd generation WagonR with bold stance ICICI Prudential plunges ~10% after PAT declines 34% in Q3FY19 Shares of ICICI Prudential plunged to a two-year low of Rs310 on the BSE, a drop of ~10% from its previous closing. Share prices plummeted as the company announced a disappointing set of numbers for the quarter ended December 2018. ICICI Prudential Life Insurance Company Ltd's gross written premium increased by ~10% yoy to Rs7,566.36cr in Q3FY19. The net premium income for Q3FY19 came in at Rs7, 482.95cr, an increase of 10.1% yoy, in line with estimates. Maruti Suzuki India launched the 3rd generation WagonR. The Big New WagonR is poised to impress customers with its bold design, enhanced space, comfort, next generation infotainment system and advanced K-series engine offering excellent fuel efficiency and driving pleasure. A true tall boy, the Big New WagonR has a robust body language with a wide stance, which makes it strikingly attractive. The Big New WagonR is engineered and built on 5th generation HEARTECT platform. The platform increases safety of occupants through effective absorption of impact and dispersion of crash energy and assures stability. Use of 40% high tensile steel provides better strength, safety, rigidity and NVH (noise, vibration, and harshness) performance. ! IRB Infra gets appointed date from NHAI for road project VK-1 , a wholly-owned subsidiary of IRB Infra Projects has received the appointed date from NHAI. The project pertains to the construction of eight lane Vadodara Kim expressway construction for 23.74km in the Padra- Vadodara section of Mumbai Vadodara Highway. The infra company made the announcement on Friday during market hours. ! Glenmark gets tentative USFDA approval for gZytiga Glenmark Pharmaceuticals Inc., USA (Glenmark), has been granted tentative approval by the USFDA for Abiraterone Acetate Tablets USP, 250 mg, a generic version of Zytiga Tablets, 250 mg, of Janssen Biotech, Inc. According to IQVIA sales data for the 12- month period ending November 2018, Zytiga Tablets, 250 mg, achieved annual sales of approximately $1.3 bn. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : LUPIN DATE : 24/01/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL :- BUY LUPIN IN CASH ABOVE 865 TGT 890 SL 840 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF TREND REVERSAL IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647